INVESTMENTS IN ASSOCIATES Sample Clauses

INVESTMENTS IN ASSOCIATES. 11.1 Investments in associated companies accounted for using the cost and equity method which consisted of : Paid-up capital (Baht) Proportion of share holding (%) As at December As at March As at December Name of company Type of business 31, 2021 31, 2020 31, 2021 31, 2020 Vibharam Hospital Co., Ltd. Hospital 2,000,000,000 2,000,000,000 33.73 33.73 Thippayabadin Co., Ltd. Trading medical instrument 522,840,000 392,840,000 38.18 38.18 Bangpo General Hospital Co., Ltd.Consolidated financial statements Indirect associated companies Hospital 350,000,000 350,000,000 28.57 28.57 Khelang Nakorn Hospital Co., Ltd. Hospital 89,708,200 89,708,200 11.99 11.99 Pawo Hospital Co., Ltd. Hospital 11,625,750 11,625,750 23.54 23.54 At equity method At cost method As at December As at March As at December Name of company 31, 2021 31, 2020 31, 2021 31, 2020 Vibharam Hospital Co., Ltd. 1,704,960,527 1,690,154,047 1,304,865,248 1,304,865,248 Thippayabadin Co., Ltd. 61,340,201 21,127,292 222,134,000 172,500,000 Bangpo General Hospital Co., Ltd. 319,717,136 318,939,772 300,000,000 300,000,000 in Thippayabadin Co., Ltd. (136,005,080) (136,005,080) Total 1,690,994,168 1,641,360,168 Consolidated financial statements Indirect associated companies Khelang Nakorn Hospital Co., Ltd. 107,476,825 109,516,558 30,882,500 30,882,500 Pawo Hospital Co., Ltd. 15,032,723 10,344,577 29,813,600 29,813,600 Total 2,208,527,412 2,150,082,246 1,736,909,391 1,682,587,245 11.2 Share of profit (loss) of associates for the three-month periods ended March 31, 2021 and 2020, were as follows : Name of company 2021 2020 Direct associated company Vibharam Hospital Co., Ltd. 668,727 30,311,843 Thippayabadin Co., Ltd. (9,421,090) (3,725,409) Bangpo General Hospital Co., Ltd. 777,364 883,169 Indirect associated companies Khelang Nakorn Hospital Co., Ltd. 2,524,738 2,023,385 Pawo Hospital Co., Ltd. 4,688,146 607,207 Total (762,115) 30,100,195 11.3 Share of other comprehensive income (loss) of associate for three-month periods ended March 31, 2021 and 2020, were as follows : Name of company 2021 2020 Direct associated company Vibharam Hospital Co., Ltd. Gain (loss) on remeasuring fair value of investment in equity - Other - (67,466) Total 14,137,750 (48,202,423) 11.4 Dividend income from investment in associated companies for the three-month periods ended March 31, 2021 and 2020, were as follows : Consolidated financial statements Separate financial statements 2021 2020 2021 2020 Vibharam Hospital Co., Ltd. - 67,4...
AutoNDA by SimpleDocs
INVESTMENTS IN ASSOCIATES. Investments in associates accounted for by cost method on the separate financial statements were as follows: In Thousand Baht Ownership interest (%) Paid-up capital Cost method Allowance for impairment At Cost - Net As at As at As at As at As at As at As at As at As at As at June December June December June December June December June December 30, 2019 31, 2018 30, 2019 31, 2018 30, 2019 31, 2018 30, 2019 31, 2018 30, 2019 31, 2018 T.K.C. Co., Ltd. 25.00 25.00 YEN 12 YEN 12 million million 846 868 (846) (868) - - Total 846 868 (846) (868) - - Investments in associates accounted for by equity method on the consolidated financial statements were as follows: In Thousand Baht Ownership interest (%) Paid-up capital Equity method Allowance for impairment Equity method - Net As at June As at December As at As at June December As atJune As atDecember As atJune As atDecember As at June As at December 30, 2019 31, 2018 30, 2019 31, 2018 30, 2019 31, 2018 30, 2019 31, 2018 30, 2019 31, 2018 Associates T.K.C. Co., Ltd. 25.00 25.00 YEN 12 YEN 12 million million - - - - - - Total - - - - - -
INVESTMENTS IN ASSOCIATES. Baht Consolidated financial statements Separate financial statements Equity Method Cost Method 1. Chiangmai Ram Hospital Co., Ltd. 838,172,159 845,481,462 47,617,004 47,617,004 2. Radio Logical Equipment Co., Ltd. 920,752 909,573 3,000,000 3,000,000 3. Synphaet Co., Ltd. 1,402,949,887 1,516,020,970 886,646,242 886,646,242 4. Piyasiri Co., Ltd. 177,259,012 132,316,659 199,939,110 199,939,110 5. Vibahavadi Medical Center Pcl. 1,828,644,412 810,588,716 560,112,526 560,112,526 6. Phayao Ram Hospital Co., Ltd. 92,441,495 83,337,240 107,000 107,000 7. Vibharam Hospital Co., Ltd. - 2,013,590,349 - 1,284,964,851 8. Legacy Golf (Thailand) Co., Ltd. 618,708,494 589,776,218 686,800,000 686,800,000 9. Buriram Ruampaet Co., Ltd. 130,721,810 127,643,824 122,696,200 122,696,200 10. Thippayabadin Co., Ltd. 51,637,572 86,746,077 150,000,000 150,000,000 11. Rajthanee Hospital Pcl. 890,470,519 282,667,309 285,154,691 283,251,514 12. Nan-Ram Hospital Co., Ltd. 21,294,022 21,110,958 20,000,000 20,000,000 13. Ramnakara Co., Ltd. 735,572,325 - 737,186,400 - 14. Seriruk Hospital Co., Ltd. 202,647,322 - - - Total 6,991,439,781 6,510,189,355 3,699,259,173 4,245,134,447 - Radio Logical Equipment Co., Ltd. - - (3,000,000) (2,150,000) - Piyasiri Co., Ltd. - - - (68,200,000) - Legacy Golf (Thailand) Co., Ltd. - - (97,384,000) (97,384,000) - Thippayabadin Co., Ltd. - - (113,505,080) - Total 6,991,439,781 6,510,189,355 3,485,370,093 4,077,400,447 Holding portion (%) Paid-up share capital (Baht) Consolidated financial statements Separate financial statements Companies Type of Business Relationship 2020 2019 2020 2019 2020 2019 1. Chiangmai Ram Hospital Co., Ltd. Hospital Shareholders/co-directors 400,000,000 400,000,000 42.89 42.89 42.89 42.89 2. Radio Logical Equipment Co., Ltd. Repair medical instruments Co-shareholders 10,000,000 10,000,000 30.00 30.00 30.00 30.00 3. Synphaet Co., Ltd. Hospital Shareholders/co-directors 1,000,000,000 1,000,000,000 32.95 32.95 32.95 32.95 4. Piyasiri Co., Ltd. Hospital Shareholders/co-directors 176,000,000 176,000,000 34.24 34.24 34.24 34.24 5. Vibahavadi Medical Center Pcl. Hospital Shareholders/co-directors 1,357,586,558 1,326,461,728 9.17 7.29 7.09 7.29 6. Phayao Ram Hospital Co., Ltd. Hospital Shareholders/co-directors 7,500,000 7,500,000 40.00 40.00 40.00 40.00 7. Vibharam Hospital Co., Ltd. Hospital Shareholders/co-directors - 1,654,800,000 - 41.10 - 41.10 8. Legacy Golf (Thailand) Co., Ltd. Golf Course Shareholders/co-directors 1,300,000,000 1,30...
INVESTMENTS IN ASSOCIATES. 15.1 Reconciles investments in associated company as at December 31, consist of: Investment in associated January 1 1,494,478 1,397,342 1,206,849 1,206,849 Plus/(Less) Share of net profit of associates 126,499 156,953 - - Share of other comprehensive income 3,939 5,433 - - Total 1,502,666 1,494,478 1,206,849 1,206,849 Investments in associated company balance ending 1,502,666 1,494,478 1,206,849 1,206,849 15.2 Detail of Investments in associated dividend income and Share of net profit of associates company as at December 31, 2022 and 2021 consist of: Aeolus Power Co., Ltd. Holding company 1,301,301 1,301,301 25.00 25.00 1,206,849 1,206,849 1,502,666 1,494,478 Total 1,301,301 1,301,301 1,206,849 1,206,849 1,502,666 1,494,478 Total 126,499 156,953 3,939 5,433 Aeolus Power Co., Ltd. Holding company 1,301,301 1,301,301 25.00 25.00 1,206,849 1,206,849 122,250 65,250 Total 1,301,301 1,301,301 1,206,849 1,206,849 122,250 65,250 company.
INVESTMENTS IN ASSOCIATES. 11.1 Investments in associated companies accounted for using the cost and equity method which consisted of : Paid-up capital (Baht) Proportion of share holding (%) As at September As at December As at September As at December Name of company Type of business Consolidated financial statements/Separate financial statements Vibharam Hospital Co., Ltd. Hospital 1,654,803,530 1,654,803,530 40.75 40.75 Thippayabadin Co., Ltd. Trading medical instrument 450,000,000 450,000,000 33.33 33.33 Bangpo General Hospital Co., Ltd. Hospital 350,000,000 350,000,000 28.57 28.57 30, 2019 31, 2018 30, 2019 31, 2018 Consolidated financial statements Indirect associated companies Khelang Nakorn Hospital Co., Ltd. Hospital 89,708,200 89,708,200 11.99 11.99 Pawo Hospital Co., Ltd. Hospital 11,625,750 11,625,750 23.54 23.54 At equity method At cost method As at December As at September As at December 31, 2018 30, 2019 Consolidated financial statements/Separate financial statements Direct associated company Vibharam Hospital Co., Ltd. 1,741,570,778 1,762,781,223 1,304,865,788 1,304,865,788 Thippayabadin Co., Ltd. 74,671,489 81,845,306 172,500,000 172,500,000 Bangpo General Hospital Co., Ltd. 307,996,041 300,791,832 300,000,000 300,000,000 Total 1,777,365,788 1,777,365,788 Consolidated financial statements Indirect associated companies Khelang Nakorn Hospital Co., Ltd. 106,726,161 101,804,620 30,882,500 30,882,500 Pawo Hospital Co., Ltd. 15,888,746 13,030,339 29,813,600 29,813,600 in Pawo Hospital Co., Ltd. - - (13,924,854) (16,783,261) Total 2,246,853,215 2,260,253,320 1,824,137,034 1,821,278,627 11.2 Share of profit (loss) of associates for the three-month and nine-month periods ended September 30, 2019 and 2018 were as follows : Name of company 2019 2018 2019 2018 Vibharam Hospital Co., Ltd. 240,789,569 43,651,473 260,359,350 89,468,046 Thippayabadin Co., Ltd. (3,931,517) (5,662,258) (7,173,818) (17,314,432) Bangpo General Hospital Co., Ltd. 3,575,129 3,353,201 7,204,208 (3,259,422) Indirect associated companies Khelang Nakorn Hospital Co., Ltd. 5,004,785 4,149,333 11,768,246 11,177,379 Pawo Hospital Co., Ltd. 2,449,150 745,277 2,858,407 (1,024,986) Total 247,887,116 46,237,026 275,016,393 79,046,585 The share of profit (loss) of directly associated company - Vibharam Hospital Company Limited as shown above for the nine-month periods ended September 30, 2019 and 2018, were the net amount of the elimination each transaction for Baht 9.19 million and Baht 8.27 million, respectively,...
INVESTMENTS IN ASSOCIATES. 15.1 Reconciles investments in associated company as at December 31, consist of: Consolidated Financial Statements Separate Financial Statements 2021 2020 2021 2020 Investment in associated January 1 1,397,342 1,329,786 1,206,849 1,208,409 Plus/(Less) Share of net profit of associates 156,953 129,184 - - Share of other comprehensive income 5,433 (310) - - Total 1,494,478 1,397,910 1,206,849 1,208,409 Investments in associated company balance ending 1,494,478 1,397,342 1,206,849 1,206,849 15.2 Detail of Investments in associated dividend income and Share of net profit of associates company as at December 31, 2021 and 2020 consist of: Aeolus Power Co., Ltd. Holding company 1,301,301 1,301,301 25.00 25.00 1,206,849 1,206,849 1,494,478 1,397,342 CIN (Thailand) Co., Ltd. Generation and supply of electricity from waste - 6,000 - 26.00 - 1,560 - 568 Total 1,301,301 1,307,301 1,206,849 1,206,849 1,494,478 1,397,342 Aeolus Power Co., Ltd 156,953 129,184 5,433 (310) Total 156,953 129,184 5,433 (310) Aeolus Power Co., Ltd. Holding company 1,301,301 1,301,301 25.00 25.00 1,206,849 1,206,849 65,250 60,750 CIN (Thailand) Co., Ltd. Generation and supply of electricity from waste - 6,000 - 26.00 - 1,560 - - Less Allowance for impairment of investments - (1,560) - - Total 1,301,301 1,307,301 1,206,849 1,206,849 65,250 60,750 CIN (Thailand) Co., Ltd. had completed the liquidation on March 29, 2021. None of the Company’s associates are publicly listed do not have published price quotations. Share of profit (loss) for the years ended December 31, 2021 and 2020 of all associated companies calculated from the financial statements for the years ended December 31, 2021 and 2020, the Company will recognize such share of profit (loss) only the shareholding proportion that the parent company has interest in which such financial statements have been audited by such company.
INVESTMENTS IN ASSOCIATES. Investments in associates accounted for by cost method on the separate financial statements were as follows: Ownership interest (%) Paid-up capital Cost method Allowance for impairment At Cost - Net As at As at As at As at As at As at As at As at As at As at September December September December September December September December September December 30, 2017 31, 2016 30, 2017 31, 2016 30, 2017 31, 2016 30, 2017 31, 2016 30, 2017 31, 2016 T.K.C. Co., Ltd. 25.00 25.00 YEN 12 YEN 12 million million 889 1,029 (889) (1,029) - - M.C.S. Steel (Xiamen) Co., Ltd. - 39.00 - YUAN 64 million - 109,629 - (15,688) - 93,941 Total 889 110,658 (889) (16,717) - 93,941 Investments in associates accounted for by equity method on the consolidated financial statements were as follows: Ownership interest (%) Paid-up capital Equity method Allowance for impairment Equity method - Net As at As at As at As at As at As at As at As at As at As at September December September December September December September December September December 30, 2017 31, 2016 30, 2017 31, 2016 30, 2017 31, 2016 30, 2017 31, 2016 30, 2017 31, 2016 T.K.C. Co., Ltd. 25.00 25.00 YEN 12 million YEN 12 million - - - - - - M.C.S. Steel (Xiamen) Co., Ltd. - 39.00 - YUAN 64 million - 123,930 - (15,688) - 108,242 Total - 123,930 - (15,688) - 108,242 In the second quarter 2017, the Company has acquired the shares of M.C.S. Steel (Xiamen) Co.,Ltd. from 39% to 74% shareholding of the Company. As a result, the status has changed from the associate to the subsidiary as at June 26, 2017 (see Note 10).
AutoNDA by SimpleDocs
INVESTMENTS IN ASSOCIATES this amendment, applicable from January 1, 2009, requires that for investments accounted for using the equity method a recognized impairment loss should not be allocated to any asset (and in particular goodwill) that forms part of the carrying amount of the investment in the associate, but to the carrying amount of the investment overall. Accordingly any reversal of that impairment loss is recognized in full.

Related to INVESTMENTS IN ASSOCIATES

  • Not an Investment Adviser The Company acknowledges that Xxxxxx Xxxxxxx is not providing any advice hereunder as to the value of securities or regarding the advisability of purchasing or selling any securities for the Fund’s portfolio. No provision of this Agreement shall be considered as creating, nor shall any provision create, any obligation on the part of Xxxxxx Xxxxxxx, and Xxxxxx Xxxxxxx is not agreeing hereby, to: (i) furnish any advice or make any recommendations regarding the purchase or sale of portfolio securities; or (ii) render any opinions, valuations or recommendations of any kind or to perform any such similar services. The Company’s engagement of Xxxxxx Xxxxxxx is not intended to confer rights upon any person (including the Fund or any shareholders, members, employees or creditors of the Company or the Fund) not a party hereto as against Xxxxxx Xxxxxxx or its affiliates, or their respective directors, trustees, officers, employees or agents, successors, or assigns.

  • Investment Advisor The Buyer is an investment advisor registered under the Investment Advisors Act of 1940.

  • Investment Management If and to the extent requested by the Advisor, the Sub-Advisor shall, subject to the supervision of the Advisor, manage all or a portion of the investments of the Portfolio in accordance with the investment objective, policies and limitations provided in the Portfolio's Prospectus or other governing instruments, as amended from time to time, the Investment Company Act of 1940 (the "1940 Act") and rules thereunder, as amended from time to time, and such other limitations as the Trust or Advisor may impose with respect to the Portfolio by notice to the Sub-Advisor. With respect to the portion of the investments of the Portfolio under its management, the Sub-Advisor is authorized to make investment decisions on behalf of the Portfolio with regard to any stock, bond, other security or investment instrument, and to place orders for the purchase and sale of such securities through such broker-dealers as the Sub-Advisor may select. The Sub-Advisor may also be authorized, but only to the extent such duties are delegated in writing by the Advisor, to provide additional investment management services to the Portfolio, including but not limited to services such as managing foreign currency investments, purchasing and selling or writing futures and options contracts, borrowing money or lending securities on behalf of the Portfolio. All investment management and any other activities of the Sub-Advisor shall at all times be subject to the control and direction of the Advisor and the Trust's Board of Trustees.

  • Investment Advisers Act The Manager is not prohibited by the Investment Advisers Act of 1940, as amended, or the rules and regulations thereunder, from performing its obligations under the Management Agreement as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.

  • Company Not an “Investment Company The Company is not, and will not be, either after receipt of payment for the Offered Shares or after the application of the proceeds therefrom as described under “Use of Proceeds” in the Registration Statement, the Time of Sale Prospectus or the Prospectus, required to register as an “investment company” under the Investment Company Act of 1940, as amended (the “Investment Company Act”).

  • Sub-Investment Advisers The Adviser may employ one or more sub-investment advisers from time to time to perform such of the acts and services of the Adviser, including the selection of brokers or dealers to execute the Trust's portfolio security transactions, and upon such terms and conditions as may be agreed upon between the Adviser and such sub-investment adviser and approved by the Trustees of the Trust, all as permitted by the Investment Company Act of 1940.

  • Holding Company and Investment Company Acts Neither the Borrower nor any of its Subsidiaries is a "holding company", or a "subsidiary company" of a "holding company", or an "affiliate" of a "holding company", as such terms are defined in the Public Utility Holding Company Act of 1935; nor is it an "investment company", or an "affiliated company" or a "principal underwriter" of an "investment company", as such terms are defined in the Investment Company Act of 1940.

  • Investment Adviser The Buyer is an investment adviser registered under the Investment Advisers Act of 1940.

  • Legal Investment On the Closing Date, the sale and issuance of the Shares and the proposed issuance of the Conversion Shares shall be legally permitted by all laws and regulations to which Purchasers and the Company are subject.

  • Non-Investment Advisory Services The Fund hereby employs the Manager to provide certain non-investment advisory services for the Portfolio, subject to the direction of the officers and the Board on the terms hereinafter set forth. Specifically, the Manager shall perform or arrange for the performance, as applicable, at its own expense (except as provided in Section 4 or unless otherwise agreed to by the Manager and the Fund, in which case at the Fund’s expense), the following services to the Fund on behalf of the Portfolio to the extent that any such services are not otherwise provided by any other service provider to the Fund: (i) monitor and evaluate the services provided to the Fund for the benefit of the Portfolio by the Portfolio’s custodian, transfer and dividend disbursing agents, printers, insurance carriers (as well as insurance agents and insurance brokers), independent public accountants, legal counsel and other persons and entities who provide similar services to the Fund for the benefit of the Portfolio; (ii) monitor the preparation of periodic reports and notices of distributions to shareholders of the Portfolio; (iii) coordinate, monitor and evaluate the daily pricing and valuation of the Portfolio’s investment portfolio; (iv) monitor the Portfolio’s compliance with recordkeeping requirements of applicable federal, state, and foreign laws and regulations; (v) assist the Portfolio to comply with the provisions of applicable federal, state, and foreign tax laws and tax regulations; (vi) assist the Portfolio to comply with the provisions of applicable federal, state, local and foreign securities, organizational and other laws that govern the business of the Fund in respect of the Portfolio, including with respect to the preparation of registration statements and other materials in connection with the offering of the Portfolio’s shares; (vii) monitor and coordinate the provision of trade administration oversight services to the Portfolio, including settlement oversight services, reconciliation services, collateral management oversight services, and similar services, including recommending corrective action; (viii) assist the Portfolio to conduct meetings of the Portfolio’s shareholders if and when called by the Board; (ix) furnish such information to the Board as the Board may reasonably require in connection with the annual approval of this Agreement, and coordinate the provision of such other information as the Board may reasonably request; and (x) provide the shareholders of the Portfolio with such information regarding the operation and affairs of the Portfolio, and their investment in its shares, as they or the Fund may reasonably request. The Manager accepts such employment and agrees to provide or coordinate the provision of the non-investment advisory services specified above in this Section 3 for the compensation provided in Section 5. The Manager is not required at its own expense to provide non-investment advisory services to the Fund under this Agreement except as specified in this Section 3. The Manager may provide additional non-investment advisory services, i.e., those not specified in this Section 3, for the benefit of the Portfolio subject to terms mutually agreed upon by the Fund and the Manager. Subject to approval or ratification by the Board, the Manager may delegate to one or more entities some or all of the services for the Portfolio described in this Section 3 for which the Manager is responsible, provided that the Manager will be responsible for supervising such entities and paying the compensation, if any, of such entities for such services to the Portfolio, except as otherwise agreed to by the Manager and the Fund.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!